Evidence map›Paper›PMID 42117693›Full record

ArticleJournal of virology2026

Cross-reactive antibody and T-cell responses after influenza virus infection in community-dwelling older adults.

Lisa van Pul, Sietske Karla Rosendahl Huber, Ronald Jacobi, Marion Hendriks, Roos van Schuijlenburg, Yannick van Sleen, Elske Bijvank, Jelle de Wit, Josine van Beek

Abstract read
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lisa van PulCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.ORCID 0000-0002-7257-3161
Sietske Karla Rosendahl HuberCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Ronald JacobiCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Marion HendriksCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Roos van SchuijlenburgCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Yannick van SleenCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Elske BijvankCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Jelle de WitCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.ORCID 0000-0003-2444-6050
Josine van BeekCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.ORCID 0000-0002-7735-9359

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seasonal influenza virus infection is one of the main causes of morbidity and mortality in older adults. The high mutation rate of influenza virus gives rise to new variants that are antigenically different, thereby evading pre-existing immune responses. In addition, due to aging of the immune system, older adults have diminished responses to infections with novel antigens. Here, we investigated longitudinal influenza virus-specific humoral and cellular responses in a cohort of community-dwelling older adults after influenza virus infection in the 2014/15 flu season in the Netherlands, a season hallmarked by vaccine mismatch. Moreover, we assessed the effect of vaccination on these responses and potential cross-reactivity. Hemagglutination inhibition assays revealed that antibodies against both vaccine and circulating strains increased 2 weeks after infection, regardless of vaccination status, indicating cross-reactivity. Although infection alone was capable of inducing antibodies, prior vaccination further increased titers. Peripheral blood mononuclear cell (PBMC) stimulation with hemagglutinin-peptide pools of circulating and vaccine strains showed induction of strain-specific T-cell responses after infection in IFN-γ ELISpots. At each timepoint, T-cell responses were similar between individuals vaccinated prior to infection and unvaccinated individuals. However, the increase in influenza virus-specific T-cell responses from 72 h to 2 weeks post-infection seemed stronger in individuals vaccinated before infection. Moreover, despite mismatch between vaccine and circulating strains, T-cell cross-reactivity was observed, albeit less pronounced than the antibody response. Overall, our study shows that community-dwelling older adults with influenza virus infection are capable of inducing virus-specific immune responses with cross-reactive potential, and vaccination further enhances these responses. IMPORTANCE: The older population is at increased risk for severe influenza virus infection due to age-related impaired immune responses to novel antigens. Consequently, older adults rely more on previously formed cross-reactive memory responses compared to younger adults. In this study, we longitudinally investigated the influenza virus-specific antibody response as well as the virus-specific T-cell response in community-dwelling older adults after influenza virus infection. We demonstrate that, despite higher age, this group of older adults was capable of inducing influenza virus-specific antibody and T-cell responses. Moreover, receiving vaccination prior to infection further increased these immune responses. Importantly, individuals mounted antibody and T-cell responses to several different influenza virus strains, indicating cross-reactivity at both levels, despite mismatch between vaccine and infection strains. Unraveling the immune responses to influenza virus infection in older adults could inform new vaccine developments and strategies that may better protect the vulnerable older population from infection.

Indexed as

Antibodies, ViralImmunity, CellularInfluenza, HumanT-LymphocytesAgedAging in PlaceCross ReactionsFemaleHumansInfluenza A virusInfluenza VaccinesMaleMiddle AgedNetherlandsSymptom BurdenAntibodies, ViralInfluenza Vaccinescellular responsecross-reactivityhumoral responseinfluenza virusolder adults

Identifiers

PMID42117693
PMCPMC13288483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.